Multidrug-resistant (MDR) A. baumannii is a rapidly emerging pathogen in healthcare settings, where it causes infections that include bacteremia, pneumonia, meningitis, and urinary tract and wound ...

Even though effective tuberculosis treatments exist, they're so hard to access in the developing world that more than one ...

Progress in understanding the molecular basis of drug resistance in cancer promises more effective treatments. Multidrug resistance, the principal mechanism by which many cancers develop ...

Multidrug resistance in cancer can be overcome by combining a drug that blocks a key enzyme with another anticancer drug, according to a study in preclinical models led by researchers at UT ...

Despite global efforts, multidrug-resistant tuberculosis in children is rising at an alarming rate, with younger children at the highest risk of mortality—urgent action is needed to reverse the ...

Cefiderocol exhibited clinical utility among a cohort of immunocompromised adult inpatients with MDR infections.

investigators from the Prospective Observational Study of Multidrug-Resistant Patient Outcomes with and without Ibalizumab in a Real-World Setting: United States (PROMISE-US) reported that patients ...

Dimicare Biotech and affiliated organizations have presented the discovery and preclinical characterization of DCB-001, a ...

Multidrug resistance, the principal mechanism by which many cancers develop resistance to chemotherapy drugs, is a major factor in the failure of many forms of chemotherapy. It affects patients ...

Theratechnologies (THTX) presented data from a real-world, observational, registry study demonstrating the efficacy and safety of ibalizumab in ...